Ascending aortic dilatation rate after transcatheter aortic valve replacement in patients with bicuspid and tricuspid aortic stenosis: A multidetector computed tomography follow-up study

摘要

BACKGROUND:Current data is lacking about the progression of ascending aortic dilatation after transcatheter aortic valve replacement (TAVR) in aortic stenosis (AS) patients with bicuspid aortic valve (BAV) and tricuspid aortic valve (TAV).This study aims to assess the ascending aortic dilatation rate (mm/year) after TAVR in patients with BAV versus TAV using a multidetector computed tomography (MDCT)follow-up and to determine the predictors of ascending aortic dilatation rate.METHODS:Severe AS patients undergoing TAVR from March 2013 to March 2018 at our center with MDCT follow-ups were included.BAV and TAV were identified using baseline MDCT.Baseline and follow-up MDCT images were analyzed,and the diameters of ascending aorta were measured.Study end point is ascending aortic dilatation rate (mm/year).Furthermore,factors predicting ascending aortic dilatation rate were also investigated.RESULTS:Two hundred and eight patients were included,comprised of 86 BAV and 122 TAV patients.Five,4,3,2,and 1-year MDCT follow-ups were achieved in 7,9,30,46,and 116 patients.The ascending aortic diameter was significantly increased after TAVR in both BAV group (43.7±4.4 mm vs.44.0±4.5 mm;P＜0.001) and TAV group (39.1±4.8 mm vs.39.7±5.1 mm;P＜0.001).However,no difference of ascending aortic dilatation rate was found between BAV and TAV group (0.2±0.8 mm/year vs.0.3±0.8 mm/year,P=0.592).Multivariate linear regression revealed paravalvular leakage (PVL) grade was independently associated with ascending aortic dilatation rate in the whole population and BAV group,but not TAV group.No aortic events occurred during follow-ups.CONCLUSION:Ascending aortic size continues to grow after TAVR in BAV patients,but the dilatation rate is mild and comparable to that of TAV patients.PVL grade is associated with ascending aortic dilatation rate in BAV patients post-TAVR.